Search

everythinglearnresearchcommunity

for

Search:↓

Achieving 80% or more scalp hair regrowth is considered a successful treatment for significant hair loss.

Real-life dosing of biologics for plaque psoriasis often deviates from recommended guidelines, especially for high-need patients.

Deep learning and explainable AI are improving scalp disorder diagnosis, but challenges in transparency and data quality remain.

The model accurately predicts hair loss severity in alopecia areata.

Many women with PCOS have undiagnosed health issues and show different symptoms based on the clinic they visit.

Using 2% tofacitinib cream with narrowband ultraviolet B improved facial vitiligo by 70% in patients who didn't respond to previous treatments, with no side effects reported.

Alopecia areata significantly lowers quality of life, especially in personal and social areas, and more so if the patient is also depressed.

An extra-strength marine protein supplement helped increase hair growth and decrease hair shedding in women with thinning hair.

Trichoscopy can help diagnose and monitor the progression of dissecting cellulitis.

JAK inhibitors effectively improve hair regrowth in alopecia areata with an acceptable safety profile.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Skin emergency severity rises with other health issues and affects multiple organs; a new grading system can improve patient care.

Individualized Homeopathic Medicine shows promise for treating alopecia with lasting hair regrowth.

Carcinosin, a homeopathic remedy, helped a young girl with alopecia areata regrow hair and reduce psychological symptoms.

The study helps doctors use patient images to understand and apply SALT scores for treating severe alopecia areata.

Men with male pattern baldness may have a higher risk of heart problems.

Isotretinoin may cause temporary, reversible facial hair growth in some women.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

Teriflunomide often causes mild to moderate hair thinning and loss in MS patients, which usually improves with or without treatment.

An intact skin barrier is crucial to prevent infection in cases of tether-induced tenosynovitis.

Females with androgenic alopecia have significantly lower vitamin D3 and ferritin levels.

Both emollients effectively reduced itching and improved skin moisture in xerotic eczema.

Venusia CeraPlus cream and lotion effectively reduce eczema severity and improve skin moisture.

Alopecia Areata significantly lowers quality of life and current treatments are inadequate, highlighting a need for better therapies and standardized treatment protocols.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Tofacitinib may help treat severe hair loss, but more research is needed.

Baricitinib is effective and safe for treating severe alopecia areata.